KEITH SCHEINBLUM, MD
PRP Treatment Specialist & Wellness Center located in Syosset, NY
HOW IT WORKS?
Also known as semaglutide, WEGOVY, slows down food leaving your stomach, reduces the amount of sugar released by your liver, and increases the amount of insulin released by your pancreas in response to high blood sugar levels. Together, these actions can result in a healthier and more regulated blood sugar level for those with diabetes and weight reduction.
Combined with healthy lifestyle changes, WEGOVY promotes weight loss by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake.
Wegovy™ FOR WEIGHT LOSS
TAKE THE FIRST STEP TOWARDS A HEALTHIER YOU
Scheinblum Medical offers weekly injections, patient monitoring, and follow-ups to ensure maximum dosage can be achieved, as well as potential side effects managed for patient safety. Our patient plan is to fully optimize accelerated weight loss to help patients reach their goals.
What is Wegovy™?
Wegovy™ is an FDA-approved injectable prescription medication to assist adults with BMI >27 to lose weight and keep the weight off. The injection is a pen for subcutaneous (under the skin) use only.
How often is Wegovy™ taken?
We will administer your Wegovy™ injection only once per week at our office.
Which doses of Wegovy™ do you offer?
You will follow a doctor-guided titration schedule if you have never used Wegovy before. You will begin with a dose of 0.25mg per injection and, throughout 4 to 5 months, slowly work up to the maximum of 2.4mg per injection if needed.
What are the most common Wegovy™ Side Effects?
The most common side effects of Wegovy™ include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distention, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder).
Other Important Safety Information
- Do not use Wegovy™ if you are allergic to liraglutide or any of its ingredients.
- Do not use Wegovy™ if you are currently pregnant, breastfeeding, or planning to become pregnant or breastfeeding.
- Do not use Wegovy™ if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy may affect the way some medicines work, and some medicines may affect the way Wegovy™ works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin.
The above is only a summary. For a full list of important safety information, click here. https://www.wegovy.com/about-wegovy/weight-loss-with-wegovy.html
Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Wegovy is an appropriate part of a weight loss plan for you.Wegovy is not FDA-approved for these uses; however, a 68-week clinical study noted these benefits.
Individual results may vary.